GBSG‐GABG 6.

Study name	GABG‐6.
Methods
Participants	Women aged 18 to 75 with histologically confirmed first isolated (that is non‐ metastasised) resectable (R0, R1) local and/or regional recurrence of invasive breast cancer, following mastectomy or breast ‐conserving therapy.
Interventions	All women receive local radiotherapy if required. Randomised interventions: 1. control; 2. doxorubicin (50 mg/m2) + docetaxel (75 mg/m2) every 3 weeks x 4.
Outcomes	Disease free survival. Overall survival. Quality of life.
Starting date	October 1998.
Contact information	Dr. H.F. Rauschecker Westermayerstr. 18, D‐83022 Rosenheim Germany Phone: +49‐8031‐ 219990 Fax: +49‐8031‐381367 Email: rauschecker@t‐online.de
Notes	Randomisation by telephone. Target accrual: 500.